PTPRD: A Positive Predictive Biomarker for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer

被引：0
|
作者：
Shen, J. [1 ]
Zhou, H. [2 ]
Liu, J. [2 ]
Zhang, Y. [2 ]
Zhou, T. [2 ]
Hong, S. [2 ]
Zhao, Y. [2 ]
Yang, Y. [2 ]
Zhao, H. [3 ]
Huang, Y. [2 ]
Fang, W. [2 ]
Zhang, L. [2 ]
机构：
[1] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Dept Clin Res, Ctr Canc, Guangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
NSCLC; Immunotherapy; Notch;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P14.14
引用
收藏
页码：S335 / S336
页数：3
相关论文
共 50 条
  • [31] Immune checkpoint inhibitors in non-small cell lung cancer
    Eberhardt, Wilfried Ernst Erich
    [J]. ONKOLOGE, 2017, 23 (10): : 838 - 844
  • [32] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    [J]. ONCOLOGIST, 2017, 22 (01): : 81 - 88
  • [33] Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
    Zhang, Feiyu
    Ferrero, Macarena
    Dong, Ning
    D'Auria, Giuseppe
    Reyes-Prieto, Mariana
    Herreros-Pomares, Alejandro
    Calabuig-Farinas, Silvia
    Durendez, Elena
    Aparisi, Francisco
    Blasco, Ana
    Garcia, Clara
    Camps, Carlos
    Jantus-Lewintre, Eloisa
    Sirera, Rafael
    [J]. CANCERS, 2021, 13 (11)
  • [34] Immunogenic chemotherapy sensitizes non-small cell lung cancer to immune checkpoint blockade therapy in preclinical models.
    Lu, Jun
    Zhu, Ying
    Wang, Jiashun
    Wang, Lufeng
    Chen, Yikai
    Cai, Weipeng
    Yuan, Jinquan
    Wang, Xiaokang
    [J]. BIOMEDICAL RESEARCH-INDIA, 2017, 28 (02): : 828 - 834
  • [35] Neoadjuvant Therapy with Immune Checkpoint Inhibitors in operable non-small cell Lung Cancer
    Hekmat, Khosro
    Bruns, Christiane J.
    [J]. CHIRURG, 2021, 92 (08): : 735 - 735
  • [36] Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer
    Conroy, Michael R.
    Dennehy, Colum
    Forde, Patrick M.
    [J]. LUNG CANCER, 2023, 183
  • [37] TTF-1 and immune checkpoint therapy in non-small cell lung cancer
    Gumbleton, Matthew
    Snyder, Eric L.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (03) : 398 - 400
  • [38] PATIENT EXPERIENCE OF IMMUNE CHECKPOINT INHIBITOR THERAPY FOR NON-SMALL CELL LUNG CANCER
    Williams, Loretta A.
    Whisenant, Meagan
    Malveaux, Donna
    Singhi, Eric K.
    Altan, Mehmet
    [J]. ONCOLOGY NURSING FORUM, 2023, 50 (02)
  • [39] Robust Prediction of Immune Checkpoint Inhibition Therapy for Non-Small Cell Lung Cancer
    Jiang, Jiehan
    Jin, Zheng
    Zhang, Yiqun
    Peng, Ling
    Zhang, Yue
    Zhu, Zhiruo
    Wang, Yaohui
    Tong, De
    Yang, Yining
    Wang, Jianfei
    Yang, Yadong
    Xiao, Kui
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [40] WDR49 mutation as a novel predictive biomarker in patients with non-small cell lung cancer with immune checkpoint inhibitors
    Shi, Zhihui
    Liu, Yaqin
    Zhao, Lele
    Chen, Lin
    Yang, Qidong
    Xiao, Mingzhe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345